Showing results (401-410 of 734) with videos related to

Sort By:
Pageof 74
Blood|October 30, 2010
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingAndrew L Feldman, Ahmet Dogan, David I Smith, et al.
Blood|July 20, 2016
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Ajay K Gopal, Scott E Smith, et al.
Haematologica|June 19, 2025
Treatment approaches and clinical outcomes in primary colorectal MALT lymphoma: a single institution retrospective study of 66 patientsSuheil Albert Atallah-Yunes, Matthew J Rees, Thomas M Habermann, et al.
The Lancet. Oncology|March 29, 2011
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 studyStephen M Ansell, Hui Tang, Paul J Kurtin, et al.
The Journal of Investigative Dermatology|January 25, 2021
Dermal Adipose Tissue Secretes HGF to Promote Human Hair Growth and PigmentationCarina Nicu, James D B O'Sullivan, Raul Ramos, et al.
British Journal of Cancer|November 18, 2010
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphomaA Younes, J M Vose, A D Zelenetz, et al.
Blood Advances|May 26, 2022
A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcomeKaran L Chohan, Jason R Young, Scott Lester, et al.
Biological Reviews of the Cambridge Philosophical Society|January 24, 2020
Neuroendocrinology and neurobiology of sebaceous glandsRichard W Clayton, Ewan A Langan, David M Ansell, et al.
Bioconjugate Chemistry|July 20, 1999
Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulationsS M Ansell, L D Kojic, J S Hankins, et al.
Bone Marrow Transplantation|November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateM A Gertz, M Q Lacy, A Dispenzieri, et al.
Pageof 74